Retinal Vein Occlusion
Showing NaN - NaN of 8
Retinal Vein Occlusion Trial in France
Active, not recruiting
- Retinal Vein Occlusion
-
Créteil, France
- +8 more
Aug 17, 2022
Macular Edema, Retinal Vein Occlusion Trial in Worldwide (KSI-301, Aflibercept, Sham Procedure)
Active, not recruiting
- Macular Edema
- Retinal Vein Occlusion
- KSI-301
- +2 more
-
Phoenix, Arizona
- +140 more
Jul 20, 2022
Collateral Damage From COVID-19 Pandemic Observed in Patients
Completed
- Age Related Macular Degeneration
- +2 more
- Questionnaire
- Data collection up to 1 year
-
Ecully, France
- +3 more
Mar 2, 2022
Retinal Vein Occlusion, Macular Edema Trial in Worldwide (dexamethasone intravitreal implant, ranibizumab)
Completed
- Retinal Vein Occlusion
- Macular Edema
- dexamethasone intravitreal implant
- ranibizumab
-
Paris, France
- +5 more
Apr 9, 2019
Ranibizumab in Real Life Setting
Completed
- Wet Age Related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion
- +3 more
-
Lanus, Buenos Aires, Argentina
- +462 more
May 20, 2016
A Long-Term Safety Study of OZURDEX® in Clinical Practice
Completed
- Retinal Vein Occlusion
- +2 more
- dexamethasone 700 μg intravitreal implant
-
Paris, France
- +3 more
Apr 18, 2016
Ozurdex® Treatment Practice in Macular Oedema Due to Retinal
Completed
- Macular Edema
- Retinal Vein Occlusion
- dexamethasone intravitreal implant
-
Paris, France(unnamed)
Feb 16, 2016
Retinal Vein Occlusion Trial in Worldwide (Aflibercept Injection (EYLEA, VEGF Trap-Eye, BAY86-5321), Sham treatment)
Completed
- Retinal Vein Occlusion
- Aflibercept Injection (EYLEA, VEGF Trap-Eye, BAY86-5321)
- Sham treatment
-
Chatswood, New South Wales, Australia
- +72 more
Oct 27, 2014